Petrochemicals markets complexity is only going to grow and grow

JOHN RICHARDSON | May 13, 2021 | 186 views

NICE WORK, if you get can get it. A trucking company in Fort Worth, Texas, is offering to pay experienced drivers $14,000 a week – $728,000 a year – as the US struggles with a nationwide shortage of truckers or lorry drivers.
This reminds me of perhaps an apocryphal tale, from the height of the last Australian mining boom. Before iron ore prices collapsed in late 2014, there was a story about workers at mining site road junctions who operated manual “Stop and Go” signs. They were said to be earning more than Australian dollar (A$) 200,000 a year.

Before you pack in your job as, say, a petrochemicals sales manager and head to Texas or mine sites in Western Australia, there is the risk that when you arrive at the door of your new prospective employer, the bubble might have already burst. This is assuming we are in bubble conditions.The pressure is clearly building in petrochemicals and other commodity markets as prices in some regions remain at record highs or continue to rise.

Today’s prices are the results of shortages of commodities supply (for example in petrochemicals, an outcome of the US winter storms), very strong demand and supply chain disruptions.I am beginning to believe that the latter is the biggest reason for commodity price inflation which is feeding through into sharp rises in the cost of finished goods – and a lack of goods availability.

It is delivering and manufacturing enough stuff that seems to be at the heart of today’s problems due to shortages of everything from container freight space and semiconductors to wooden pallets, tin cans, metal drums, cardboard – and US truck drivers.

Spotlight

Coherus BioSciences

Coherus BioSciences is the leading biologics platform company solely focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medicines in regulated markets worldwide. Founded in 2010, Coherus is a late-stage biologics platform company focused on the global biosimilar market. Headquartered in the San Francisco Bay Area and composed of a team of industry veterans with decades of experience in pioneering biologics companies, our goal is to become a global leader in the biosimilar market by leveraging our team's collective expertise in key areas such as process science, analytical characterization, protein production and clinical-regulatory development. Our commercialization partnerships include global pharmaceutical companies in Europe, Asia and Latin America.

OTHER ARTICLES
Chemical Management

Demographics are reshaping petrochemicals trade flows, investment patterns and demand

Article | June 29, 2021

TEN YEARS AGO, fellowblogger Paul Hodgesand Ifirst highlighted the leading rolethat changing demographics would play in reshaping petrochemicals supply and demand. We have been emphasising the importance of demographics ever since. Demographics have, of course, always been a critical shaper of economies throughout human history. But during the last 70 years, there have been such major changes in demographics that the study of demographics must be at the very heart of your company’s strategy. The Babyboomer generation in the West led to a surge in demand as the rapid increase in babies born in the 1950s and early 1960s joined the workforce from the 1970s onwards. This helps explain high levels of inflation during that decade because too much demand was chasing too little supply. Another driver of inflation was the Middle East embargos against oil exports to the West because of the West’s support for Israel. Then came the 1990s and first the integration of Eastern Europe into the global economy. This helped dampen inflationary pressures because of the plentiful supply of workers in the east willing to work for low wages in export-focused factories. This reduced the cost of finished goods in the West. Next came Deng Xiaoping’s critically important“southern tour”in the early 1990s and China’s gradual integration into the global economy. China increasingly leveraged its very youthful population to again make cheap goods to export to the West. Hundreds of millions of young people were willing to migrate from the countryside to China’s coastal cities to work in export-focused manufacturing plants. The world began to talk about the “China price” and how it was further depressing global inflation.

Read More
Chemical Management

Future-Proofing the Chemical Industry with Digitalization

Article | May 1, 2021

Over the next five to seven years, the chemical sector will place a greater emphasis on sustainability, and digitization will play a significant part in this. Reducing resource use, pollution, energy consumption, and waste are some of its main applications. Additionally, it will increase demand for a circular economy supported by IoT, AI, and other digital technologies. Some of the systems now in place or being used in the sector include autonomous solutions that enable lower energy usage, dispatching systems for effective logistics and strategies for sustainable power and fuel consumption. Chemical players making the switch to digital platforms have a chance to triumph if they move swiftly and update their operational models in accordance with a few common success characteristics. In fact, according to our study, making the correct decisions can increase total earnings before interest, taxes, depreciation, and amortization by 3 percent or more (EBITDA). The Next Step of Operational Excellence The same level of transformation is available with digital technology for optimal performance, together with success-enabling measures. The same level of corporate participation and realignment will also be necessary for the effective implementation of digital technology. Finance and telecoms were early leaders in adopting digital technology faster than the chemical sector, which has just recently started to move in more significant numbers toward digitalization. A circular economy in the sector is also being enabled by the use and evaluation of digital technology. The "Right to Fix" movement is being driven by governments and legislators in Europe and the US, and small and medium-sized businesses in the industry are expected to invest in technology that makes it easier to repair electronic items with the least amount of waste. On a side note, by enabling the re-use of resources and products throughout the supply chain, digitalization with lean manufacturing (LM) would enable businesses to improve operational excellence and create value, thereby supporting the circular economy goal. Conclusion Given its extensive safety and regulatory requirements, the chemical sector has evolved slowly. However, as the global economy changes, some skills will become obsolete and others essential. The interconnectedness of people, processes, and technology, as well as the requirement for real-time insight at the levels closest to the action, are among the basic principles of Industry 4.0. These values have existed for some time and are an extension of our teams' current operational excellence initiatives. Digital transformation is not a technology endpoint but rather the following stage in the process and business evolution as the chemicals industry advances continuously.

Read More
Chemical Management

We can solve the plastic waste crisis but we don’t have much time

Article | July 22, 2021

IN 2015, a global agreement was reached that 8m tonnes a year of plastic waste entering the oceans was unacceptable, according to this September 2020 article in The Conversation. This was the amount of plastic that was estimated to have ended up in the oceans in 2010. “Several international platforms emerged to address the crisis, including Our Ocean, the UN Sustainable Development Goals and the G7 Ocean Plastic Charter, among others,” continued the article. But in 2020, an estimated 24m-34m tonnes of plastic waste was forecast to enter our lakes, rivers and oceans. This could reach as much as 90m tonnes in 2030 if the current trajectory continued, said The Conversation. This is the type of information out there, free to view on the internet and accessible via a very quick Google search, representing a major challenges for our industry. I cannot of course verify the numbers. But they are out there. Also out there is a May 2019 article by the World Economic Forum (WEF), which provided a good summary of research into what experts believed was the scale of the waste problem in the developing world.

Read More
Chemical Management

Boom in petrochemicals demand guaranteed but we must grow sustainably

Article | June 3, 2021

ONE OF THE GREATEST achievements of the last 30 years has been the fall in the number of people living in extreme poverty.In 1999, 1.9bn of the world’s population were living on less than $1.90, the Word Bank’s definition of extreme poverty. Despite setbacks caused by the pandemic, this had fallen to 698m by October 2020. Income levels alone are not enough to escape the life-threatening agony of extreme poverty. There is no point in having money if the essential goods and services to spend your money on are not available. Critical to poverty alleviation has been sufficient supply of all the things that people in the rich world take for granted. The raw materials to make the vast majority of manufactured goods include petrochemicals and polymers. Nearly all the major manufacturing chains would not have been able to function without petrochemicals. Think of medical equipment, syringes, blood bags, hospital gowns, face masks, pill bottles and medicine blister packs. None of the above could have been produced without petrochemicals. As people emerged out of extreme poverty and as economies became wealthier, modern-day medical services became more widely available.

Read More

Spotlight

Coherus BioSciences

Coherus BioSciences is the leading biologics platform company solely focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medicines in regulated markets worldwide. Founded in 2010, Coherus is a late-stage biologics platform company focused on the global biosimilar market. Headquartered in the San Francisco Bay Area and composed of a team of industry veterans with decades of experience in pioneering biologics companies, our goal is to become a global leader in the biosimilar market by leveraging our team's collective expertise in key areas such as process science, analytical characterization, protein production and clinical-regulatory development. Our commercialization partnerships include global pharmaceutical companies in Europe, Asia and Latin America.

Related News

Chemical Management

908 Devices Enters Initial Production Phase of US Department of Defense Aerosol and Vapor Chemical Agent Detector Program

businesswire | September 28, 2023

908 Devices Inc. a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces that it has entered the initial production phase of the Aerosol and Vapor Chemical Agent Detector (AVCAD) program. The company and its partner on the project, Smiths Detection, will initially produce 122 systems in this next phase. The systems, which have been in development and testing since 2019, are a next generation chemical detector, designed to detect, identify, alarm and report the presence of traditional and advanced threat vapors and aerosols. Using a wireless remote alarm capability, the AVCAD, which can be mounted or portable, will support missions for the U.S. Army, Navy, Coast Guard, and Marine Corps. To ensure the highest level of detection and to meet the key deployment needs of the U.S. Department of Defense, the AVCAD features the company’s High Pressure Mass Spectrometry (HPMS) technology. Mass spectrometry is considered to be the gold standard of analytical lab techniques. 908 Devices’ proprietary HPMS technology leverages micro scale geometries and high frequency electronics to enable an efficient regime of vacuum operation for a significant reduction in device size and power consumption compared to conventional lab instruments. “908 Devices is pleased to continue working with the U.S. Department of Defense and our partner, Smiths Detection, on this enterprise, multi-year program,” said Kevin J. Knopp, CEO and Co-founder of 908 Devices. “Being selected for this limited production phase validates our technology as a new standard for chemical detection and we are truly honored to have a role in protecting our U.S. military.” About 908 Devices 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma/biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic sampling and separations, software automation, and machine learning.

Read More

Chemical Management

Danimer Scientific and Chevron Phillips Chemical Expand Collaboration to Include Application Development for Rinnovo™ Polymers

businesswire | September 21, 2023

Danimer Scientific, Inc. a leading next-generation bioplastics company focused on the development and production of biodegradable materials, today announced it is expanding its collaboration with Chevron Phillips Chemical (“CPChem”) to explore development and commercialization of cast extrusion films, blown extrusion films, injection molded parts and rotational molded parts using Rinnovo™ polymers produced in a loop slurry reactor process. Rinnovo™ is a type of polyhydroxyalkanoate (“PHA”) synthesized from lactones produced using Danimer’s proprietary Novo22™ catalyst technology, which can be used in the production of biodegradable alternatives to traditional plastics. The collaboration expands on Danimer and CPChem’s previously announced agreement, in which Danimer is evaluating the use of CPChem’s loop slurry reactor design to develop a continuous reactor system in the manufacturing process for Rinnovo™. Stephen E. Croskrey, chief executive officer of Danimer, said, “Our business relationship with CPChem continues to yield results, and we’re excited for the further opportunities that lie ahead. CPChem’s Research and Technology lab in Bartlesville, Oklahoma, is a premier facility staffed with world-class talent that we believe will accelerate the path toward adoption of Rinnovo™ materials in high-volume applications that will assist in lowering the cost to serve key markets.” Opened in 1950 by Phillips 66, CPChem’s Bartlesville facility contains first-class research equipment allowing for rapid testing of products across various processing conditions. Additionally, the facility’s testing and analytical capabilities provide a more rapid feedback loop, accelerating the development and optimization of resin formulations. “We continue to be excited about the potential of our MarTECH® process technology and related collaborations to advance Danimer’s Rinnovo™, another CPChem initiative that can help accelerate change for a more sustainable future,” said Venki Chandrashekar, CPChem vice president of research and technology. About Danimer Scientific Danimer is a pioneer in creating more sustainable, more natural ways to make plastic products. For more than a decade, its renewable and sustainable biopolymers have helped create plastic products that are biodegradable and compostable and return to nature instead of polluting our lands and waters. Danimer’s technology can be found in a vast array of plastic end products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films and injection-molded articles, among others. Danimer holds more than 430 granted patents and pending patent applications in more than 20 countries for a range of manufacturing processes and biopolymer formulations.

Read More

Chemical Management

Actylis Launches a New cGMP WFI Generation, Storage, and Distribution System with Additional ISO Class 7 Manufacturing Space

businesswire | September 26, 2023

Actylis, a leading global manufacturer of critical raw materials and performance ingredients for the life sciences and specialty chemicals markets, today announced the launch of Water for Injection (WFI) and additional ISO Class 7 manufacturing space at its Baie d’Urfé site in Montreal, Canada. Used for the preparation of media, buffers, and other aqueous solutions, Actylis’ WFI meets monographs for pharmacopoeias worldwide, and can be provided in both custom and standard packaging configurations. Gilles Cottier, CEO at Actylis, said: “Today we are delighted to announce the opening of this new WFI system at our Baie d’Urfé site. Investment in this new WFI generation, storage, and distribution system reflects our ongoing commitment to support our customers, and to continuously develop our range of products and services. The new system positions us to be a preferred outsource partner for our customers’ buffer solutions. We understand that capacity is often a pinch-point for our customers, and we are delighted to be able to propose this option to them.” Damien O’Rourke, SVP Manufacturing Operations at Actylis added: “Our new WFI system, redundant with our Limerick, Ireland WFI capabilities, incorporates the latest advancements in water purification technology, adhering to Good Manufacturing Practices (cGMP) that guarantees the production of WFI that meets or exceeds the most rigorous quality standards. In addition to the services this enables for our customers, the investment provides Actylis and our customers with a robust multi-site business continuity plan to ensure dependable supply.” Jean-Francois Raymond, Site Director, elaborated on some of the specifics of the system: “We are excited to have this new system here at Baie d’Urfé come on stream. The WFI system is fully qualified with all supporting validation documents, and is capable of generating and maintaining water as per required USP and PhEur/BP specifications of Water for Injection.” The new system’s strategic location in Montreal positions it as a pivotal hub for biopharmaceutical companies across North America and beyond. Its proximity to major transportation networks ensures timely distribution of WFI to manufacturers, enabling them to streamline their production processes and meet growing market demands. About Actylis Actylis is a leading global manufacturer and supplier of differentiated specialty ingredients to life sciences and specialty chemicals end markets. With business operations in ten countries, Actylis manufactures and supplies over 4,500 chemical compounds used principally by the pharmaceutical, biopharmaceutical, nutritional, agricultural and specialty chemical industries. Building on a series of strategic acquisitions, Actylis has integrated their manufacturing, R&D, quality, and sourcing capabilities to create a worldwide supplier of critical raw materials that includes a robust manufacturing footprint. Its global operations include a significant presence on the ground in North America, Europe, India, and China. Actylis is well positioned to innovate new solutions, ensure quality, and customize products to meet customers’ specific needs. Its expanded capabilities and decades of global sourcing expertise are especially valuable now that supply chain management is a critical strategic issue for companies worldwide.

Read More

Chemical Management

908 Devices Enters Initial Production Phase of US Department of Defense Aerosol and Vapor Chemical Agent Detector Program

businesswire | September 28, 2023

908 Devices Inc. a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces that it has entered the initial production phase of the Aerosol and Vapor Chemical Agent Detector (AVCAD) program. The company and its partner on the project, Smiths Detection, will initially produce 122 systems in this next phase. The systems, which have been in development and testing since 2019, are a next generation chemical detector, designed to detect, identify, alarm and report the presence of traditional and advanced threat vapors and aerosols. Using a wireless remote alarm capability, the AVCAD, which can be mounted or portable, will support missions for the U.S. Army, Navy, Coast Guard, and Marine Corps. To ensure the highest level of detection and to meet the key deployment needs of the U.S. Department of Defense, the AVCAD features the company’s High Pressure Mass Spectrometry (HPMS) technology. Mass spectrometry is considered to be the gold standard of analytical lab techniques. 908 Devices’ proprietary HPMS technology leverages micro scale geometries and high frequency electronics to enable an efficient regime of vacuum operation for a significant reduction in device size and power consumption compared to conventional lab instruments. “908 Devices is pleased to continue working with the U.S. Department of Defense and our partner, Smiths Detection, on this enterprise, multi-year program,” said Kevin J. Knopp, CEO and Co-founder of 908 Devices. “Being selected for this limited production phase validates our technology as a new standard for chemical detection and we are truly honored to have a role in protecting our U.S. military.” About 908 Devices 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma/biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic sampling and separations, software automation, and machine learning.

Read More

Chemical Management

Danimer Scientific and Chevron Phillips Chemical Expand Collaboration to Include Application Development for Rinnovo™ Polymers

businesswire | September 21, 2023

Danimer Scientific, Inc. a leading next-generation bioplastics company focused on the development and production of biodegradable materials, today announced it is expanding its collaboration with Chevron Phillips Chemical (“CPChem”) to explore development and commercialization of cast extrusion films, blown extrusion films, injection molded parts and rotational molded parts using Rinnovo™ polymers produced in a loop slurry reactor process. Rinnovo™ is a type of polyhydroxyalkanoate (“PHA”) synthesized from lactones produced using Danimer’s proprietary Novo22™ catalyst technology, which can be used in the production of biodegradable alternatives to traditional plastics. The collaboration expands on Danimer and CPChem’s previously announced agreement, in which Danimer is evaluating the use of CPChem’s loop slurry reactor design to develop a continuous reactor system in the manufacturing process for Rinnovo™. Stephen E. Croskrey, chief executive officer of Danimer, said, “Our business relationship with CPChem continues to yield results, and we’re excited for the further opportunities that lie ahead. CPChem’s Research and Technology lab in Bartlesville, Oklahoma, is a premier facility staffed with world-class talent that we believe will accelerate the path toward adoption of Rinnovo™ materials in high-volume applications that will assist in lowering the cost to serve key markets.” Opened in 1950 by Phillips 66, CPChem’s Bartlesville facility contains first-class research equipment allowing for rapid testing of products across various processing conditions. Additionally, the facility’s testing and analytical capabilities provide a more rapid feedback loop, accelerating the development and optimization of resin formulations. “We continue to be excited about the potential of our MarTECH® process technology and related collaborations to advance Danimer’s Rinnovo™, another CPChem initiative that can help accelerate change for a more sustainable future,” said Venki Chandrashekar, CPChem vice president of research and technology. About Danimer Scientific Danimer is a pioneer in creating more sustainable, more natural ways to make plastic products. For more than a decade, its renewable and sustainable biopolymers have helped create plastic products that are biodegradable and compostable and return to nature instead of polluting our lands and waters. Danimer’s technology can be found in a vast array of plastic end products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films and injection-molded articles, among others. Danimer holds more than 430 granted patents and pending patent applications in more than 20 countries for a range of manufacturing processes and biopolymer formulations.

Read More

Chemical Management

Actylis Launches a New cGMP WFI Generation, Storage, and Distribution System with Additional ISO Class 7 Manufacturing Space

businesswire | September 26, 2023

Actylis, a leading global manufacturer of critical raw materials and performance ingredients for the life sciences and specialty chemicals markets, today announced the launch of Water for Injection (WFI) and additional ISO Class 7 manufacturing space at its Baie d’Urfé site in Montreal, Canada. Used for the preparation of media, buffers, and other aqueous solutions, Actylis’ WFI meets monographs for pharmacopoeias worldwide, and can be provided in both custom and standard packaging configurations. Gilles Cottier, CEO at Actylis, said: “Today we are delighted to announce the opening of this new WFI system at our Baie d’Urfé site. Investment in this new WFI generation, storage, and distribution system reflects our ongoing commitment to support our customers, and to continuously develop our range of products and services. The new system positions us to be a preferred outsource partner for our customers’ buffer solutions. We understand that capacity is often a pinch-point for our customers, and we are delighted to be able to propose this option to them.” Damien O’Rourke, SVP Manufacturing Operations at Actylis added: “Our new WFI system, redundant with our Limerick, Ireland WFI capabilities, incorporates the latest advancements in water purification technology, adhering to Good Manufacturing Practices (cGMP) that guarantees the production of WFI that meets or exceeds the most rigorous quality standards. In addition to the services this enables for our customers, the investment provides Actylis and our customers with a robust multi-site business continuity plan to ensure dependable supply.” Jean-Francois Raymond, Site Director, elaborated on some of the specifics of the system: “We are excited to have this new system here at Baie d’Urfé come on stream. The WFI system is fully qualified with all supporting validation documents, and is capable of generating and maintaining water as per required USP and PhEur/BP specifications of Water for Injection.” The new system’s strategic location in Montreal positions it as a pivotal hub for biopharmaceutical companies across North America and beyond. Its proximity to major transportation networks ensures timely distribution of WFI to manufacturers, enabling them to streamline their production processes and meet growing market demands. About Actylis Actylis is a leading global manufacturer and supplier of differentiated specialty ingredients to life sciences and specialty chemicals end markets. With business operations in ten countries, Actylis manufactures and supplies over 4,500 chemical compounds used principally by the pharmaceutical, biopharmaceutical, nutritional, agricultural and specialty chemical industries. Building on a series of strategic acquisitions, Actylis has integrated their manufacturing, R&D, quality, and sourcing capabilities to create a worldwide supplier of critical raw materials that includes a robust manufacturing footprint. Its global operations include a significant presence on the ground in North America, Europe, India, and China. Actylis is well positioned to innovate new solutions, ensure quality, and customize products to meet customers’ specific needs. Its expanded capabilities and decades of global sourcing expertise are especially valuable now that supply chain management is a critical strategic issue for companies worldwide.

Read More

Events